As of November 9, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of Petmed Express Inc. The largest reported stake is SilverCape Investments Limited's, at 12.07%. 4 filings are on record since December 11, 2025 (Schedule 13D/A, June 29, 2026).
Sell to companies like Petmed Express Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Renaissance Technologies LLC · Sole voting: 1,131,230 · Shared voting: 0 · Sole dispositive: 1,131,230 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-08-13
- · Holder: SilverCape Investments Limited · Percent: 12.07% · Shares: 2,579,696 · SCHEDULE 13D/A
- · Holder: Diveroli Investment Group LLC · Percent: 1.83% · SCHEDULE 13D
- · Holder: SilverCape Investments Limited · Percent: 12.28% · SCHEDULE 13D/A
Petmed Express Inc has 4 Schedule 13D or 13G filings on record since 2025-12-11. 2 holders' latest filing reports 5% or more of common stock, par value $.001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| SilverCape Investments Limited | 12.07% | 2,579,696 | SCHEDULE 13D/A, 2026-06-29 | 2026-06-29 |
| Renaissance Technologies LLC | 5.29% | 1,131,230 | SCHEDULE 13G/A, 2026-08-13 | 2026-06-30 |
| Diveroli Investment Group LLC | 1.83% | 391,757 | SCHEDULE 13D, 2026-02-11 | 2025-01-11 |
Holding shares or following this stake? See who's behind Petmed Express Inc and the warning signs.
Free to see. No signup.
Keep reading
More on Petmed Express Inc and the records around it.
Petmed Express Inc elsewhere on the record
- Leadership changes Sep 2026
- Who owns it
Companies that share a holder
- Diveroli Investment Group LLC also filed stake reports on 6 other companies: AYRO, Inc. (May 2026), BATTALION OIL CORP (Jan 2026), NOODLES & Co (Dec 2025)
- Renaissance Technologies LLC also filed stake reports on 46 other companies: AMERICAN PUBLIC EDUCATION INC (Aug 2026), Bolt Biotherapeutics, Inc. (Aug 2026), Commercial Vehicle Group, Inc. (Aug 2026)
Watch Petmed Express Inc
Get an email when Petmed Express Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Petmed Express Inc?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Petmed Express Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Petmed Express Inc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
7 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| SilverCape Investments Limited | 2,579,696 | 0 | 2,579,696 | 0 | SCHEDULE 13D/A, 2026-06-29 |
| Peter Kennedy | 0 | 2,579,696 | 0 | 2,579,696 | SCHEDULE 13D/A, 2026-06-29 |
| Renaissance Technologies LLC | 1,131,230 | 0 | 1,131,230 | 0 | SCHEDULE 13G/A, 2026-08-13 |
| Renaissance Technologies Holdings Corporation | 1,131,230 | 0 | 1,131,230 | 0 | SCHEDULE 13G/A, 2026-08-13 |
The latest filing identifies Petmed Express Inc by CUSIP 716382106 and gives its principal executive office as 420 SOUTH CONGRESS AVENUE, DELRAY BEACH, FL 33445 (SCHEDULE 13G/A, 2026-08-13).
Source of funds (Item 3)
Item 3 of the of the Prior Statement is not being amended by this Amendment No. 2.SilverCape Investments Limited, SCHEDULE 13D/A, 2026-06-29
Purpose of Transaction (Item 4)
SilverCape Investments Limited
Item 4 of the Prior Statement is hereby amended and supplemented to add the following: On June 29, 2026, SilverCape sent a (the "Letter") to the Issuer's Chief Executive Officer and board of directors providing a revised non-binding proposal (as revised, the "Proposal") to take the Issuer private by acquiring 100% of the Issuer's outstanding Common Stock at a price of $3.00 per share of Common Stock in cash (the "Potential Transaction"). The Letter was also publicly disclosed by press release (the "Press Release") on June 29, 2026. The Letter and Press Release also outline and summarize SilverCape's rationale for the Proposal as well as various reasons why SilverCape believes the Issuer's board of directors should engage with SilverCape on the Proposal and Potential Transaction. The Proposal for the Potential Transaction was (and remains) non-binding and is subject in all respects to, among other things: (a) the Reporting Persons' further due diligence and (b) the execution of a mutually acceptable definitive agreement with terms and conditions customary for transactions of the type contemplated by the Proposal (the "Definitive Agreement"), including, without limitation, that the Issuer and its board of directors take all actions necessary to render inapplicable the Issuer's shareholder rights plan or other similar antitakeover protections that are or could become applicable in connection with the transactions contemplated by the Letter and the Press Release, the …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-06-29; the filing has the rest
Diveroli Investment Group LLC
As the holders of a significant interest in the Issuer, the Reporting Persons may have influence over the corporate activities of the Issuer, including activities which may relate to the transactions described in clauses (a) through (j) of the instructions to Item 4 of Schedule 13D. The Reporting Persons from time to time intends to review their investments in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the shares of common stock of the Issuer (the "Shares") in particular, as well as other developments and other investment opportunities. Based upon such review, the Reporting Persons will take such actions in the future as the Reporting Persons may deem appropriate in light of the circumstances existing from time to time. If the Reporting Persons believe that further investment in the Issuer is attractive, whether because of the market price of the Shares or otherwise, they may acquire Shares or other securities of the Issuer either in the open market or in privately negotiated transactions. Similarly, depending on market and other factors, the Reporting Persons may determine to dispose of some or all of the Shares currently owned by the Reporting Persons or otherwise acquired by the Reporting Persons either in the open market or in privately negotiated transactions. The Reporting Persons may also …The first part of Item 4 of the SCHEDULE 13D filed 2026-02-11; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-12-11 | SilverCape Investments Limited | 12.28% | SCHEDULE 13D/A |
| 2026-02-11 | Diveroli Investment Group LLC | 1.83% | SCHEDULE 13D |
| 2026-06-29 | SilverCape Investments Limited | 12.07% | SCHEDULE 13D/A |
| 2026-08-13 | Renaissance Technologies LLC | 5.29% | SCHEDULE 13G/A |
Questions about who owns Petmed Express Inc
Who owns Petmed Express Inc?
On this page, 2 holders' latest ownership filings report 5% or more of Petmed Express Inc: SilverCape Investments Limited (12.07%, Schedule 13D/A, filed 2026-06-29) and Renaissance Technologies LLC (5.29%, Schedule 13G/A, filed 2026-08-13).
Who are the largest shareholders of Petmed Express Inc?
By the share each holder's latest filing reports, the largest holders of Petmed Express Inc on this page are SilverCape Investments Limited (12.07%) and Renaissance Technologies LLC (5.29%).
When did SilverCape Investments Limited buy into Petmed Express Inc?
The filings give report dates, not purchase dates. The earliest filing from SilverCape Investments Limited on this page is the Schedule 13D/A, filed 2025-12-11, reporting 12.28%; its latest, Schedule 13D/A filed 2026-06-29, reports 12.07%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 4 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Petmed Express Inc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| September 21, 2026 | Leadership change: Tamar Elkeles appointed, Director | — | Leadership changes | Source |
| September 17, 2026 | Leadership change: Jeffrey Allen Willard appointed, Chief Executive Officer, and 1 more | — | Leadership changes | Source |
| June 26, 2026 | Leadership change: Leah A. Solivan departs, Director | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for Petmed Express Inc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.